Saboo Sodium Chloro Ltd has secured in-principle approval from BSE Limited to launch a rights issue of partly paid-up equity shares worth ₹47.57 crore. The approval, granted on June 23, 2026, allows the company to use the exchange's name in its Letter of Offer and related advertisements, provided it includes the required disclaimer clauses. This move is aimed at raising capital to support the company's financial activities, though the specific use of proceeds was not disclosed in the filing.

The approval from BSE is subject to the company completing all necessary legal and statutory formalities before finalizing the offer documents. The exchange has clarified that the permission does not warrant or certify the correctness or completeness of the offer's contents, nor does it guarantee the listing of the securities. Investors are advised to conduct independent inquiries before subscribing to the issue.

Key Details of the Approval

The following table summarizes the key details of the regulatory approval received by the company:

Compliance and Next Steps

To proceed with the issue, Saboo Sodium Chloro Ltd must fix a record date with at least three working days' advance notice to the exchange. The company is also required to disclose the rights issue price at least three working days prior to this record date. Additionally, the company must ensure that it has entered into agreements with all depositories for the dematerialization of the securities and offer investors the option to receive allotments in dematerialized form.

The company must also comply with the provisions of Section 186 and 188 of the Companies Act, 2013, and Regulation 23 of the SEBI (LODR) Regulations, 2015, prior to filing the listing application. A secretarial auditor's certificate confirming Overseas Direct Investment (ODI) compliance must be procured before the filing. The basis of allotment will require approval from the designated stock exchange, even in the event of under-subscription.

Saboo Sodium Chloro Limited has accepted the resignation of Kamal Sharma from the position of Independent Director, effective from the close of business hours on June 10, 2026. The resignation follows Sharma's inability to devote the necessary time and attention to the role due to personal reasons involving family commitments. The Board of Directors formally noted the resignation during its meeting held on June 22, 2026, at the company's Registered Office in Jaipur.

The decision was communicated to the Bombay Stock Exchange Limited in accordance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company disclosed that the cessation of directorship was due to personal reasons. The resignation letter, dated June 10, 2026, was addressed to the Board and cited personal commitments as the primary reason for stepping down.

Details of Resignation

The company provided specific details regarding the change in directorship as required under SEBI regulations. The following table summarizes the key particulars:

Kamal Sharma, who held the Director Identification Number (DIN) 09720912, expressed gratitude to the Board and management for their support during his tenure. He confirmed that he did not hold any directorships in other listed companies nor any positions on board committees of listed entities at the time of his resignation. The company has completed the necessary formalities to record the change.